Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The report highlights the successful IPO of Shaanxi Tourism, which leverages its rich tourism resources and strong operational experience to build competitive advantages through a combination of performance-driven tourism, cable car operations, and dining services [22][24][34] - The report emphasizes the resilience of the cultural tourism industry amid ongoing trends to expand domestic demand and promote consumption, suggesting that Shaanxi Tourism's future growth will be supported by new performance projects and cable car capacity upgrades [36] Summary by Sections Retail and Social Services Market Review - The retail and social services indices rose by 4.23% and 4.71% respectively during the week of January 5 to January 9, 2026, with the Shanghai Composite Index increasing by 3.82% [12][14] - Among the sub-sectors, the supermarket segment showed the highest growth, with an increase of 8.18% year-to-date [15][17] Industry Dynamics: Shaanxi Tourism - Shaanxi Tourism, a leading regional tourism company, successfully listed on the Shanghai Stock Exchange on January 6, 2026, becoming the first A-share listed company of the year [22] - The company reported significant revenue contributions from its tourism performance and cable car operations, with a net profit margin and gross profit margin remaining high post-pandemic [24][27] - Revenue breakdown for the first half of 2025 shows that tourism performance accounted for 60.2%, cable car operations for 35.8%, and dining services for 4.0% [24] Investment Recommendations - The report recommends focusing on high-end gold and fashion jewelry brands, highlighting companies like Chow Tai Fook and Chao Hong Ji, which are expected to benefit from market trends [39] - It also suggests monitoring offline retail companies adapting to market changes and AI-enabled cross-border e-commerce leaders, with specific recommendations for Yonghui Supermarket and Aiying Room [39] - In the cosmetics sector, the report emphasizes brands that capture emotional value and innovate with safe ingredients, recommending companies like Mao Ge Ping and Proya [40]

Group 1 - The core viewpoint of the articles highlights the successful implementation of new agricultural technologies in Huzhou, particularly in the cultivation of medicinal mushrooms, which is expected to yield higher profits for local farms [1] - The "Scientist Industry Service Team" has been instrumental in connecting local enterprises with advanced agricultural technologies, facilitating the transfer of knowledge and expertise from academic institutions to practical applications in the field [1][2] - The introduction of a new intelligent logistics system at Proya (Zhejiang) Cosmetics Co., Ltd. has significantly improved production efficiency, demonstrating the positive impact of technological innovation on operational processes [2] Group 2 - The Huzhou Science and Technology Innovation Service Center emphasizes the challenges faced by enterprises in finding quality collaboration projects due to limitations in expertise and influence, which the "Scientist Industry Service Team" aims to address [2] - The city has established multiple "Scientist Industry Service Teams" focusing on various sectors, including biomedicine and digital factories, to provide technical diagnostics and solve critical technological challenges for local businesses [1][2] - Plans for the current year include strengthening partnerships with national academic societies and research institutions to enhance the expert resources available to the "Scientist Industry Service Team," aiming for at least 10 collaborative outcomes in professional talent development and technology transfer [2]

Investment Rating - The industry investment rating is "Positive" (首次) [1] Core Insights - The beauty and personal care industry is experiencing a mixed performance, with the beauty care index declining by 1.70% in December 2025, ranking 24th among all primary industries [15] - The medical beauty sector is seeing innovation with the approval of new products, such as the cross-linked recombinant collagen implant by Jiangsu Chuangjian Medical Technology Co., which is expected to inject new momentum into the market [7][34] - Lin Qingxuan, a pioneer in the "oil-based skincare" segment, has successfully listed on the Hong Kong Stock Exchange, marking a significant milestone for domestic high-end skincare brands [8][39] Summary by Sections Market Review - In December, the beauty care index reported a decline of 1.70%, underperforming the broader market, which saw the Shanghai Composite Index increase by 2.06% [15] - For the entire year of 2025, the beauty care index showed a cumulative increase of 0.39%, again lagging behind the Shanghai Composite Index's 18.41% growth [15] Medical Beauty - Jiangsu Chuangjian Medical's cross-linked recombinant collagen implant has been approved, making it the fifth such product in China and the first cross-linked version [34] - The industry is shifting from single product competition to a full-chain layout, with companies like Jinjian Biological and Junzi Biological also making significant advancements in the recombinant collagen space [34][36] Cosmetics - Lin Qingxuan has established itself as a leader in the high-end domestic skincare market, achieving the highest retail sales among domestic brands in 2024 [39] - The company has built a comprehensive supply chain and employs an OMO (Online-Merge-Offline) model to enhance customer engagement and sales [39][49] - Lin Qingxuan's core product, the camellia oil essence, has a high repurchase rate of 33.5%, indicating strong customer loyalty [51] Investment Recommendations - The report recommends focusing on differentiated upstream medical beauty product manufacturers and chain medical beauty institutions, highlighting companies like Meili Tianyuan Medical Health and Aimeike [9][53] - In cosmetics, the report suggests investing in brands that innovate in emotional value and safe ingredients, with a focus on domestic brands like Maogeping and Lin Qingxuan [54]

Group 1: Fund Sales and Regulations - The China Securities Regulatory Commission (CSRC) issued new regulations to lower public fund subscription fees and sales service fees, aiming to reduce investor costs and enhance returns [2] - As of Q3 2025, the total amount of public funds held by wealth management products reached 1.34 trillion yuan, reflecting a growth of over 44% since the beginning of the year [2] Group 2: Fund Performance and Distribution - In 2025, over 3,600 funds announced distributions totaling more than 240 billion yuan, marking a 7.5% increase from 2024 [6] - Bond funds accounted for over 60% of the total distributions, with approximately 150 billion yuan distributed [6] Group 3: Market Trends and New Fund Launches - A total of 44 new funds were launched in the first week of January 2026, with active equity and index funds being the primary focus [5] - The number of new A-share accounts reached 2.6 million in December 2025, a 30.54% increase year-on-year, indicating a significant rise in market participation [8] Group 4: Private Fund Performance - In 2025, private equity funds achieved an average return of 37.75% in stock strategies, outperforming other strategies [15] - Quantitative stock long strategies demonstrated superior performance, benefiting from systematic advantages [15] Group 5: Regulatory Developments - The CSRC and the Ministry of Finance introduced a whistleblower reward system for reporting securities and futures violations, with rewards up to 1 million yuan [3] - The public fund industry saw a record number of management changes in 2025, with 462 changes across 162 fund managers [7]

Group 1: Fund Sales Regulations - The China Securities Regulatory Commission (CSRC) issued new regulations to lower public fund sales fees, aiming to reduce investor costs and enhance returns [1] - As of Q3 2025, the total value of public funds held by bank wealth management products reached 1.34 trillion yuan, reflecting a growth of over 44% since the beginning of the year [1] Group 2: Whistleblower Policy - The CSRC and Ministry of Finance announced a whistleblower reward program for reporting securities and futures violations, with rewards up to 1 million yuan [2] Group 3: Fund Issuance - In the first week of January 2026, 44 new funds were launched, with active equity and index funds being the primary focus [3] Group 4: Fund Dividends - Over 3,600 funds announced dividends in 2025, totaling over 240 billion yuan, a 7.5% increase from 2024 [4] - Bond funds contributed significantly to dividends, accounting for over 60% of the total [4] Group 5: Hong Kong MPF Performance - The Hong Kong Mandatory Provident Fund (MPF) achieved a record investment return of 219.2 billion HKD in 2025, with an annual return rate of 16.73% [5] Group 6: Fund Management Changes - The public fund industry saw a record number of management changes in 2025, with 462 changes involving 162 fund managers [6] Group 7: A-Share New Accounts - A-share new account openings reached 2.6 million in December 2025, a 30.54% increase year-on-year, marking the highest annual total since 2022 [7][8] Group 8: Enhanced Index Funds - Enhanced index funds showed significant performance improvement in 2025, with an average net value growth rate exceeding 32% and over 80% achieving excess returns [9] Group 9: Fund Manager Actions - Notable fund managers made significant adjustments to their holdings in Q4 2025, with various companies experiencing changes in investment [10] Group 10: Fund Purchase Limits - Several actively managed equity funds lifted purchase limits as the A-share market surpassed 4,000 points, indicating a positive market sentiment [11] Group 11: ETF Naming Update - A major ETF in China underwent a name change to reflect its scale exceeding 400 billion yuan, enhancing its market presence [12] Group 12: Private Fund Performance - Private funds reported strong performance in 2025, with stock strategies averaging a return of over 37%, outperforming other strategies [14]

Group 1 - The investment focus of Chinese beauty brands is shifting towards upstream pharmaceutical sectors to enhance raw material research and development capabilities, as seen with Proya's investment in Beijing Huaguan Biotechnology [3] - The overall trend in the Chinese beauty industry indicates that leading companies are investing in upstream technologies and new brands to build an ecological closed loop and enhance competitiveness [3] Group 2 - The oral care market is experiencing continuous upgrades, with Q1 2025 sales reaching 1.72 billion yuan, a year-on-year increase of 27.7%, driven by innovative products that meet diverse consumer needs [5] - New products include usmile whitening toothpaste, ice spring mouthwash, BOP teeth whitening strips, and others that utilize advanced technology for oral health [5] Group 3 - Starbucks is transitioning its strategy from sporadic collaborations to a systematic approach in the beauty sector, appointing a former E.L.F. executive to enhance its marketing efforts and address growth stagnation in North America [6] - This strategic shift reflects a trend of blurred brand boundaries in response to consumer upgrades, aiming to transform Starbucks into a lifestyle symbol [6] Group 4 - Sephora has introduced six domestic beauty brands, including Yeoseo and BABI, to adjust its product selection logic amid performance pressures, despite some consumer concerns about diluting its high-end positioning [7][8] - The introduction of these brands aims to attract younger consumers and shift from a "channel brand" to a "user brand," although it faces challenges in consumer perception [7][8] Group 5 - Huaxizi has become the first Chinese beauty brand to enter Ulta Beauty, marking a significant breakthrough in the U.S. market and showcasing the international competitiveness of Chinese beauty brands [9] - The brand combines traditional Chinese craftsmanship with modern technology, focusing on cultural and quality exports, and has products available in over 110 countries [9] Group 6 - Lin Qingxuan is set to become the first "high-end domestic skincare stock" listed on the Hong Kong Stock Exchange, with a projected revenue of 1.052 billion yuan in the first half of 2024, reflecting a year-on-year growth of 98.3% [10] - The company has a strong product line, including the best-selling camellia oil, and plans to use IPO funds for brand building and channel expansion, targeting Southeast Asian markets [10]

Market Overview - The cosmetics sector increased by 1.29% on January 9, with Shuiyang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 4120.43, up 0.92%, while the Shenzhen Component Index closed at 14120.15, up 1.15% [1] Individual Stock Performance - Shuiyang Co., Ltd. (300740) closed at 25.65, up 5.90% with a trading volume of 223,500 shares and a transaction value of 561 million yuan [1] - Qingsong Co., Ltd. (300132) closed at 8.70, up 2.47% with a trading volume of 253,700 shares [1] - Beitaini (300957) closed at 41.20, up 1.85% with a trading volume of 163,500 shares and a transaction value of 261 million yuan [1] - Other notable stocks include Furuida (600223) at 7.53 (+1.76%), Jiaheng Jiahua (300955) at 39.89 (+1.68%), and Huaye Fragrance (300886) at 26.64 (+1.06%) [1] Capital Flow Analysis - The cosmetics sector experienced a net outflow of 31.72 million yuan from institutional investors and 34.45 million yuan from speculative funds, while retail investors saw a net inflow of 66.18 million yuan [2] - Individual stock capital flows indicate that Qindao Jinwang (002094) had a net inflow of 13.96 million yuan from institutional investors, while it faced a net outflow of 1.23 million yuan from speculative funds [3] - Other stocks like Qingsong Co., Ltd. (300132) and Beitaini (300957) also showed mixed capital flows, with varying levels of net inflows and outflows from different investor categories [3]

附件 化妆品监督抽检产品合格信息（2025年第01号） 附原文： 广元市市场监督管理局关于化妆品"你点我检"抽检情况的通告（2025年第01号） 为进一步加强化妆品质量安全监管，深入贯彻落实化妆品质量安全监管要求，拓宽社会各界参与化妆品质量安全监督渠道，今年，我局组织开展了化妆 品"你点我检"专项抽检。 根据征集的公众意见，本次专项抽检任务涉及儿童类和祛斑美白类两个大类，共计16批样品，检验结果均为合格。（详见附件）特此通告。 广元市市场监督管理局 2025年12月24日 中国质量新闻网讯 近日，四川省广元市市场监督管理局网站发布化妆品"你点我检"抽检情况通告（2025年第01号）。 | 序 | | 产 品 | | 注册人/备 | | 注册证编 | 生产单位 | | | | | 检 验 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | 产品名称 | 类 | 生产日期/批号 | 案人名称 | 注册人/备案人地址 | 号/备案编 | 名称 | 被抽样单位 | 检验机构 | 检验依据 | 检 ...

Core Viewpoint - The recent announcement of share reduction by Maogeping Company, a leading domestic high-end cosmetics brand, has attracted significant market attention, highlighting the wealth and financial strategies of its founders, Maogeping and his family [2][3]. Group 1: Company Overview - Maogeping Company, listed on the Hong Kong Stock Exchange, has a market capitalization of HKD 42.25 billion as of January 8, 2024, with projected revenue exceeding HKD 3.8 billion for the year [2]. - The company was founded in 2000 by Maogeping, who transitioned from a film makeup artist to a prominent figure in the beauty industry [2]. Group 2: Wealth and Shareholding Structure - Maogeping and his spouse, Wang Liqiong, have a combined wealth of RMB 12.5 billion, ranking them 2188th on the 2025 Hurun Global Rich List [3][4]. - The family holds a significant portion of the company's shares, with Maogeping and Wang Liqiong owning approximately 29.22% of the equity, while other family members collectively hold over 50% [5][6]. Group 3: Financial Performance - The company has experienced rapid growth since 2021, with a compound annual growth rate (CAGR) of 35.04% in revenue and 38.56% in net profit, significantly outpacing industry averages [9]. - Revenue figures from 2021 to 2024 show a consistent upward trend, with revenues increasing from RMB 1.577 billion in 2021 to RMB 3.885 billion in 2024, and net profit rising from RMB 331 million to RMB 881 million [9][10]. - In the first half of 2025, the company reported revenues of RMB 2.588 billion and a net profit of RMB 670 million, reflecting year-on-year growth rates of 31.3% and 36.1%, respectively [9][10]. Group 4: Product and Market Position - Maogeping's flagship brand contributes over 99% of the company's revenue, with a diverse product range that includes over 400 items across makeup, skincare, and fragrance categories [10][11]. - The company maintains a high gross margin, consistently above 83%, which is significantly higher than competitors like Proya and Shanghai Jahwa [9][10]. - Notable products include the "Luxury Caviar Cushion" and "Light Sense Soft Color Powder Cake," each generating over RMB 200 million in retail sales in the first half of 2025 [13]. Group 5: Future Prospects - The company is expected to continue its growth trajectory with plans to expand into new markets and product lines, including fragrances, supported by the establishment of a new R&D center in Hangzhou [10]. - As of October 2025, the family's wealth has reportedly increased to RMB 20.5 billion, indicating a successful financial strategy and business expansion [10].

Group 1 - The core point of the news is that the controlling shareholder and several executive directors of Mao Geping Cosmetics plan to collectively reduce their holdings by up to 17.2 million H shares, accounting for no more than 3.51% of the company's total issued shares, due to personal financial needs [1][2] - The planned reduction is expected to raise approximately 1.4 billion HKD based on the closing price of 82 HKD per share on the announcement date [1] - Despite the reduction, the company emphasizes that it will not lead to a change in control or significantly impact governance and ongoing operations [1][2] Group 2 - The beauty industry is experiencing frequent reduction plans, with Mao Geping's announcement occurring just after its first anniversary of listing, amidst a backdrop of declining valuations in the domestic beauty market [2][3] - Mao Geping's stock price peaked at 130.6 HKD per share, but has since fallen by about 33%, resulting in a market cap loss of nearly 20 billion HKD [2] - The company reported a revenue of 2.588 billion CNY for the first half of 2025, a year-on-year increase of 31.3%, and a net profit of 670 million CNY, up 36.1%, although revenue growth has begun to slow [2][7] Group 3 - The domestic beauty industry is shifting from an incremental market to a stock market, with a high entry and elimination rate among brands [6] - High-end beauty products are becoming a significant focus, with sales growth for products priced over 1,000 CNY increasing by 531.6% during the 2025 Double Eleven shopping festival [6] - Mao Geping maintains a high gross margin of over 80%, but faces scrutiny over its low R&D investment, which was only 15.257 million CNY in the first half of 2025 [7] Group 4 - The company is characterized by a high degree of founder centralization, with Mao Geping's personal brand being integral to the company's identity and operations [4][5] - The company is constructing a research and development center in Hangzhou, expected to be completed by the end of 2026, to enhance product design and development capabilities [7] - Balancing family wealth management with corporate growth while addressing R&D shortcomings and reducing dependence on the founder will be crucial for the company's sustained presence in the high-end beauty market [7]